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ABSTRACT 
Iron deficiency is the most commonly reported nutritional deficiency in the world 
and has been linked to cognitive impairments in children. Our aim was to assess the 
impact of iron deficiency on cognition using neonatal piglets as a model for human 
infants, as neurodevelopment in piglets resembles that of humans. Piglets were fed one 
of three diets with varying concentrations of iron (Fe): adequate (6.3mg Fe/kg body 
weight [BW]), mildly deficient (1.5mg Fe/kg BW), or severely deficient (0.63 mg Fe/kg 
BW). Piglets were placed on the diet at two days of age for four weeks. On days 7, 
14,21, and 28 hemoglobin (P = 0.0360) levels were reduced in piglets fed deficient 
diets. Skin pigmentation, as measured by a colorimeter in L*a*b* color space, showed 
reduced magenta color in the iron deficient piglets (P < 0.0001), correlating with 
hematocrit levels (R2 = 0.76). The effect of iron deficiency on cognition was assessed 
using a hippocampal-dependent spatial T-maze task. Severely deficient piglets were 
unable to acquire the task (P = 0.3937), while mildly deficient piglets had lower 
performance when the reward location was reversed than those on the adequate diet (P 
= 0.0321). This behavioral deficit was mirrored by a decrease in iron concentration in 
the hippocampus, but not the prefrontal cortex. Gene expression of several neurotrophic 
factors and proinflammatory cytokines, as well as whole-brain and hippocampal volume, 
were not affected. 
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CHAPTER 1 
INTRODUCTION 
Iron deficiency is the primary cause of anemia, which affects roughly a quarter of 
the world’s population (1). As the most prominent micronutrient deficiency in the world, 
iron deficiency affects all age groups, with the most common being children between the 
ages of 0 and 5  (1). It was previously thought that iron deficiency was not a large cause 
for concern, as the neonate was protected through iron stores obtained as a fetus, in all 
but the most severe cases of maternal anemia (2). However, it is now known that even 
a mild case of iron deficiency in the mother can reduce the iron stores in the fetus, 
resulting in a neonatal iron deficient condition (3). Iron deficiency in the neonate can 
occur for several reasons, including having a diabetic mother and being born 
prematurely (4), both of which are present in developed and developing countries. As 
the incidence of both these conditions are increasing worldwide (5-7), it is likely that iron 
deficiency in infants will become an increasing concern within the human health 
industry. 
Early-life nutrition can have important consequences for the neonate (8, 9). The 
potential effects of postnatal iron deficiency on brain growth and cognitive development 
are of particular interest, as the human brain undergoes a major growth spurt during the 
first year of life (10, 11). Disruption of these early developmental processes may have 
long-lasting, and even permanent, effects on brain structure and function (12, 13). The 
hippocampus is a particularly important brain region involved in learning and memory, 
which is highly vulnerable to various stressors during this sensitive period (14). 
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Iron has been shown to be necessary for important functions in the brain, 
including energy metabolism, neurotransmission, and myelination (15), as well as 
decreases in brain volume (16). Disrupting these functions in the neonate can result in 
cognitive impairments and behavioral problems in children (15, 17), many of which are 
long-lasting (4, 18-20). These behavioral changes have also been observed in animal 
models (21, 22), along with differences in the expression of neurotrophic factors (23, 
24), proteins involved in myelination (25, 26), and decreased hippocampal volume (12). 
The neonatal piglet is an emerging animal model for studying neurodevelopment 
due to its parallels with human brain structure (27) and perinatal growth patterns (28). 
These similarities make the piglet an excellent model for assessing the neurological 
effects of nutritional deficiencies or interventions during the neonatal period. Piglets are 
also a suitable model for iron deficiency, as they are born with limited stores of iron 
(approximately 50 mg), just as humans are born with limited stores, and can quickly 
become deficient  without a supplement or adequate dietary source (29). Therefore, the 
aims of this study were to create both a mild and severe neonatal iron deficiency in the 
piglet and to determine the consequences of these statuses on hippocampal-dependent 
learning and memory. 
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CHAPTER 2 
LITERATURE REVIEW 
Iron deficiency (ID) is the most commonly reported nutritional deficiency in the 
world, and iron deficiency anemia (IDA), which is the collection of symptoms caused by 
ID, affects roughly two billion people (1).  ID in the neonate can be due to the fetus 
obtaining low iron stores during gestation, which can have many causes besides 
general maternal nutrition.  The occurrence of maternal diabetes during pregnancy, 
premature birth, and smoking during pregnancy are all possible reasons for IDA in 
neonates (4, 30). It is now known that even a mild case of ID in the mother can reduce 
the iron stores in the fetus (3).  As the incidence of maternal diabetes and preterm births 
are increasing worldwide (5-7), it is likely that ID in infants will become an increasing 
concern within the human health industry. 
 
2.1 IRON IN THE PERIPHERY 
Absorption of iron in the small intestine 
Iron is an essential mineral for almost all living organisms, so its absorption is 
extremely important to maintain proper function. Natural iron exists in one of two 
categories: heme iron (ferrous, Fe2+ attached to protoporphyrin IX) or non-heme iron 
(usually Fe2+ or ferric, Fe3+) (31).  Heme iron appears to be absorbed directly by the 
enterocyte through a mechanism that is still being understood (32, 33), while non-heme 
iron requires different proteins to be absorbed (33).  The ability to absorb ferric iron is 
due to a ferroreductase, called duodenal cytochrome B (Dcytb), which is located on the 
cell membrane of enterocytes of the duodenum of the small intestine. This enzyme 
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reduces the ferric iron to the ferrous form (34), a process that is facilitated by acidic 
conditions and inhibited by phytates and polyphenols (35). Ferrous iron can then be 
bound by transferrin and absorbed by the enterocyte through divalent metal-ion 
transporter 1 (32). It is generally converted back to the ferric form for transport or 
storage by proteins, such as transferrin and ferritin; however, both forms of iron are 
found in the body and are constantly converted between each other (33). Once inside 
the cell, iron is sequestered and transported while constantly bound by chaperone 
proteins, such as transferrin and ferritin, in order to minimize free-radical generation 
caused by the reactive nature of iron and to minimize invasive bacteria from acquiring 
access to it (32). 
 
Biological functions of iron in the periphery 
Once inside the body, iron is very versatile and has many uses. A large percent 
of iron goes towards the synthesis of heme in the liver and bone marrow, a molecule 
made up of protoporphyrin IX and a ferrous iron ion (36). After the heme molecule is 
synthesized, it is incorporated into heme-containing proteins, or hemoproteins, such as 
hemoglobin, myoglobin, and cytochromes (37). Both hemoglobin (in the blood, as part 
of the erythrocyte) and myoglobin (in the muscle) bind to oxygen, ( while cytochromes 
are important in energy metabolism and are used for the transfer of electrons in the 
electron transport chain (31). Hemoproteins are also used by enzymes, such as 
oxygenases and peroxidases, as well as enzymes involved in nitric oxide synthesis (36) 
and in the production of radical and reactive compounds produced by immune cells to 
protect the body from invasive bacteria (38). 
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Non-heme iron that is not used to synthesize heme is mainly employed in the 
synthesis of iron-sulfur proteins (36).  These proteins have many different functions, 
including energy production, as part of the electron transport chain of the mitochondria, 
and are a part of various enzymes, such as aconitase and succinate dehydrogenase, 
which are important in the citric acid cycle (31). The remaining iron is also involved as a 
cofactor for many different enzymes, such as those involved in sensing oxygen during 
hypoxic conditions (hypoxia induced transcription factor prolyl and asparaginyl 
hydroxylases) (39) and DNA synthesis (ribonucleotide reductase) (40), as well as iron 
transport and storage (31). 
 
Measuring peripheral iron status 
      There are several different tests to asses iron status which are summarized in 
Table 2-1. Traditionally, the most commonly used technique to determine iron stores in 
the body, which are generally lower in ID, was to test for iron in the blood serum using 
plasma emission spectrometry (41, 42). However, this measure is not very robust, as its 
accuracy can be affected by many different factors,  including diurnal rhythm variation 
(43), inflammation (44), and bleeding (45). For these reasons, the use of this technique 
has decreased in popularity in recent years. Another test of iron status is the total iron-
binding capacity, which is calculated by adding the amount of iron in the blood plasma 
to the unsaturated iron-binding capacity (measured by magnesium carbonate 
absorption (46)) (40, 47).  In a state of ID, total iron-binding capacity is usually (although 
not always) increased (48). 
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The test that correlates best with the state of iron stores in the body is serum 
ferritin levels, which decrease in the ID condition (49). This test can be measured by 
using an enzyme-linked immunosorbent assay (ELISA) radioimmunoassay (RIA), or 
immunoradiometric assay (IRMA) (50-52). However, even this indicator can be affected 
by conditions, such as rheumatoid arthritis (53), hepatitis (54), and chronic kidney 
disease (55). Serum transferrin receptor levels are also an indicator of iron status and 
they increase in the ID condition (56). The main problem with this test is the lack of a 
standard comparator for clinical use (57); however, it is possible that a ratio of serum 
transferrin receptor to serum ferritin may be a better way to determine iron stores (58). 
The most common and cost-effective method of assessing iron status in the body 
is the hematocrit (or packed cell volume) test (59).  However, because of the 
inaccuracies caused by elevation, hydration status, or smoking (59), the measurement 
of hemoglobin levels can be used along with hematocrit in order to more accurately 
assess iron status (29). However, hematocrit and hemoglobin are some of the last 
factors to be affected by ID, and may not be the best measures for early detection (38).  
When diagnosing ID in a clinical setting a complete blood count is usually determined, 
which includes hemoglobin and hematocrit, as well as a red and white blood cell count 
and platelet count (60).  The large number of tests available to determine iron stores, 
and the fact that multiple tests are used in clinical practice, indicates that all of these 
tests have their limitations and are more accurate when used together. 
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Peripheral symptoms of iron deficiency 
 One of the early symptoms of IDA is anisocytosis (40), which means that the red 
blood cells are unequal in size.  During IDA, iron stores are lowered and the red blood 
cells being synthesized are smaller, due to less heme available for erythropoiesis (the 
synthesis of red blood cells) (61).  As the deficiency progresses, iron stores and heme 
availability are lowered further and the red blood cells produced become even smaller 
(microcytic), as well as more pale in color (hypochromic) (40). These hematopoietic 
effects result in symptoms, such as elevated heart rate, rapid breathing, weakness, and 
impaired exercise tolerance with an increased propensity to produce lactic acid, 
occurring because of the bodies’ impaired ability to deliver oxygen to tissues (40, 62). 
 Non-hematopoietic symptoms of ID generally occur in epithelial tissues, which 
have a very rapid turnover, possibly due to the fact that DNA synthesis can be impaired 
in IDA (40).  Gastritis, or inflammation of the stomach lining, has been described in 
patients with IDA (63); however, this may also be due to a chronic stomach infection 
with helicobacter pylori causing bleeding leading to ID (64). Finger nails are another 
rapidly proliferating tissue that can be affected by ID.  Koilonychia, or “spoon nails” (65), 
is the the condition in which the fingernails become concave and brittle (66). The tongue 
and mouth can also be affected by ID, causing the atrophy of the lingual papillae on the 
tongue, leading to a smooth and waxy appearance, as well as the corners of the mouth 
becoming irritated, a condition called angular stomatitis (40). Hair growth can also be 
negatively impacted by ID leading to a condition called alopecia, or hair loss, which is 
more commonly found in women (67). However, alopecia does not occur in all cases of 
ID, and the link between ID and hair loss is still being investigated (68). Common initial 
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symptoms in adults with IDA are decreased productivity and performance at work (69), 
disrupted circadian rhythms (70), and decreased immune system function causing 
increased susceptibility to certain types of infection and chronic inflammation (40, 70). 
Most peripheral symptoms of IDA are reversible with iron supplementation (40). 
 
2.2 IRON IN THE BRAIN 
Transport of iron into the brain 
 Since iron is necessary for energy production (among other important functions), 
and the brain’s energy needs are very high, the brain has  significant iron requirements 
(32). The mechanism by which iron from the diet enters the brain and maintains normal 
operation is not completely understood; however, progress is being made to answer this 
key question (32). The blood-brain barrier seems to be a major control point for the 
entry of iron into the brain (the cerebral spinal fluid), although the choroid plexus is also 
a location of regulation for iron entry (71). The blood-brain barrier is important in this 
process, as it prevents the brain from having direct access to the iron in the blood 
plasma, allowing for greater regulation (32). Transferrin receptors are present on the 
blood-brain barrier to allow for the binding and endocytosis of transferrin-bound iron into 
the brain (72). The rate of iron entry into the brain is increased during ID (73), which is 
due to an increased amount of transferrin receptors present on the cells of the blood-
brain barrier during this status (74), as well as a possible role for regulation by 
astrocytes (71). It is also likely that the transferrin protein releases the iron atom as it 
enters the brain, as researchers found that mice with defective divalent metal 
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transporter 1 have decreased brain uptake of iron (75); however, this mechanism is still 
being investigated. 
 Once the iron is inside these blood-brain barrier cells, much less is known about 
how it is distributed to different brain regions. Most likely transferrin (secreted by the 
choroid plexus, which is another point of regulation) is the primary method for the 
distribution of iron in the brain (72); however, it is also possible for iron to be transported 
by binding to ferritin (32). The iron can then be taken up by cells in various brain regions 
that express receptors for transferrin and/or ferritin, with the expression of these 
receptors as the mechanism of regulation (71). This leads to an uneven distribution of 
iron between the various brain regions, which changes throughout the lifetime (72). In 
general, the globus pallidus, red nucleus, substantia nigra, and caudate putamen have 
higher iron concentrations throughout life, and the brain tends to accumulate iron with 
age (32).  
 
Biological functions of iron in the brain 
Iron has many functions in the brain; one of the most obvious is its importance in 
energy production. The brain requires a large amount of adenosine triphosphate (ATP) 
for neurons to transmit signals down the axon, transmit signals across synapses, and 
maintain ionic gradients (32). In addition to its role in the periphery, iron is important in 
the production of ATP, due to its role as a cofactor for enzymes in the citric acid cycle, 
as well as part of the cytochromes that accept electrons in the electron transport chain 
(32). The generation of sufficient ATP is important for proper brain function. 
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Iron is essential for the function of some neurotransmitters because it is a 
cofactor for enzymes involved in their synthesis, such as tyrosine hydroxylase and 
tryptophan hydroxylase  (32, 76). These enzymes convert tyrosine to L-dopamine and 
tryptophan to 5-hydroxytryptophan, both of which are necessary for the functioning of 
the dopaminergic system (72). It has been shown that the dopamine D2 receptor and 
GABA receptor systems are affected by ID (70); however, it is possible that other 
neurotransmitter systems may be affected as well (72). 
Myelination is another important feature of the brain that involves iron.  Myelin is 
a layer of protein and fat that surrounds the axon of neurons to minimize the loss of an 
electrical potential, which is the neuron signal (70). The exact mechanism of how iron 
contributes to myelination is not known (77). Mice that have an increased expression of 
transferrin also have an increase in myelinating proteins and phospholipids (78) and ID 
mice have a decrease in overall myelination similar to an essential fatty acid deficiency 
(70). 
Finally, neuron structure has been shown to be affected by ID, indicating that iron 
has some role in dendritic branching (13, 79). The exact mechanisms behind these 
observations are not clear; however, decreased expression of brain derived 
neurotrophic factor (BDNF) and increased expression of nerve growth factor (NGF) 
found in ID rats (23, 24), which may contribute to these differences. 
 
Measuring brain iron status 
Iron levels in the brain do not always correspond to iron levels in the periphery 
(80), highlighting the importance of a robust method for evaluating the amount of iron in 
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the brain. In an animal research setting or post-mortem human study, brain tissue is 
commonly digested by an acid cocktail and measured by mass spectrometry (81, 82). 
However these tests are extremely invasive and cannot be used in clinical settings. 
Recently, magnetic resonance imaging (MRI) has been employed as a non-invasive 
method to assess iron status in the brain.  
The use of powerful magnetic fields in MRI causes the spin of hydrogen atoms in 
water molecules of the subject’s body to align. When the magnetic field is removed, the 
atoms return to their original state, releasing characteristic radio-frequency 
electromagnetic radiation, which is detectible by the machine. As the magnetic field is 
repeatedly pulsed on and off, the values of T1 and T2 are measured and recorded. T1 
refers to the time that the magnetic field is applied, whereby the hydrogen atoms are 
aligning their spins with the applied magnetic field. T2 refers to the time it takes for the 
spins to relax to their base state when the field is removed. The radio-frequency 
electromagnetic radiation can be run through a mathematical algorithm to create two 
main kinds of three dimensional image of the subject, called magnitude and phase (83). 
In order to create an image that depicts relative iron concentrations, there are 
multiple types of analysis that can be utilized. Most of these types of analysis involve T2 
weighting and the application of various filters to the phase image (84). When water 
molecules are in the vicinity of iron atoms, the value of T2 changes by a detectable 
amount. One of the popular methods using this information is called susceptibility 
weighted imaging (SWI), which is now used in clinical practice to help detect regions 
with higher iron concentrations and micro bleeds in the brain (85). This technique has 
not yet been used to detect deficiency conditions, possibly because low iron in a brain 
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region results in higher concentrations of water that can reduce the accuracy of the 
measurements (86). 
 
Symptoms of iron deficiency in the brain 
 ID can cause a decrease in brain iron concentrations, which can lead to 
numerous behavioral symptoms, such as irritability, apathy, lack of concentration, and 
cognitive deficits (see section 3) (32). Most behavioral symptoms are reversible with 
iron supplementation, but some symptoms, if the deficiency occurred at a critical time, 
can be irreversible (22). Also, many brain disorders have been linked to increased iron 
concentrations in various areas of the brain, such as Alzheimer’s Disease and 
Parkinson’s Disease, as well as disorders occurring because of decreased brain iron, 
such as restless leg syndrome and attention deficit hyperactivity disorder (ADHD) (32). 
Disruption of the dopamine pathway by ID has been linked to behavioral 
problems in animals that resemble ADHD (87) and include impaired temperature 
regulation, disrupted circadian rhythms, and increased pain threshold (88, 89). 
Decreased brain iron levels, as well as increased brain transferrin levels, have been 
found in patients with restless leg syndrome, a disorder described by an “uncontrollable 
urge to move the legs”; however, the mechanism by which this is caused is not known 
(32). 
Deficits in motor development are also a symptom of ID in the neonate. Both 
human and rodent studies have found delays in the development of motor skills (90), 
such as lower scores in the Bayley Scales of Infant Development (a test which 
measures motor and cognitive development) for humans (17, 91, 92) and delayed 
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development of surface righting, bar hold, forelimb placing, and negative geotaxis in 
rodents (22). 
 
2.3 IRON DEFICIENCY AND COGNITION 
The link between ID and cognitive deficits has been well established and several 
review articles have been written on this topic (4, 18, 70, 90). The reasons behind these 
cognitive deficits are less well known; however, much progress has been made in the 
last decade. Both human and animal studies have shown that ID negatively affects 
learning and memory in the neonate (especially in the hippocampus, a brain region 
important in learning and memory (14)), and that this effect can be very long lasting.  
 
Human studies 
 One of the first studies to look at the effect of ID on cognition in humans used the 
Bayley Scales of Infant Development and compared infants who were given iron 
supplements to those given a placebo. The results showed an improved score for the 
iron supplemented group (93), which resulted in a surge of interest in this topic (70). 
Many different studies have looked at ID during various times of development; however, 
the most sensitive period (and the period that can cause the most irreversible damage) 
is the neonatal period, which is between 0 and 24 months of age (90). Although 
supplementation with iron has been shown to correct many of the cognitive deficits 
lower developmental I.Q. and achievement test scores have still been found after 
treatment (94). 
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Many studies have investigated the impact of neonatal iron status at various 
times during this critical period and the effects that decreased iron levels have on 
cognition. In Papua New Guinea, infants who were given an iron dextran shot at two 
months of age had increased levels of attention at one year of age (95). A study done in 
Costa Rica found that infants who had lower iron levels scored lower in the Bayley 
Scales of Infant Development tests in both mental and motor test scores (94). In 
Guatemala, researchers found that an intramuscular injection of iron dextran improved 
Bayley Scales of Infant Development test scores after just one week, while oral 
supplementation did not show an effect within the week studied (96). Studies by 
researchers in Chile found a similar relationship between low iron levels and lower 
Bayley Scales of Infant Development scores (92). While Indonesia researchers found 
that oral supplementation of iron in anemic children reduced deficits in visual attention 
and concept acquisition compared to children who were not given supplementation (97). 
Also in Indonesia, researchers found that when 12-18 month old infants that were 
diagnosed with IDA were given an oral iron intervention, Bayley Scales of Infant 
Development scores significantly improved compared to those given a placebo, even 
after only four months of supplementation (91). Finally, in Israel, it was found that 
children who were born premature and had low ferritin levels at birth performed 
significantly worse on tests involving spatial cognition and processing of auditory signals 
when tested at nine to ten years of age, even though their hemoglobin levels had 
returned to normal (98, 99), demonstrating that IDA during this critical period can cause 
long term deficits. 
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Rodent studies 
 Animal models have greatly helped to advance the knowledge of ID and its 
effects on cognitive performance. The fact that the avoidance response is affected by ID 
was one of the first cognitive aspects studied in rodents. Rats who were placed on an ID 
diet at an early age showed deficits in both passive avoidance, where the rat had to 
inhibit its activity (i.e., not leave a platform and enter a chamber) in order to avoid shock, 
and active avoidance (i.e., where rats had to move into another chamber of the testing 
area in order to avoid shock) (100, 101). Fear conditioning (as measured by heart rate 
deceleration in a cage where the rat had been shocked previously, as well as exposure 
to a tone that was played during the shock in a novel cage) was also impaired in ID rats 
(102).  
ID diets also resulted in cognitive deficits in the Morris Water Maze pool, a 
hippocampal-dependent task which requires the rat to develop a spatial map of the area 
surrounding the pool in order to reach a submerged platform, as measured by an 
increased time to reach the platform (103). Similar deficits were observed in a water Y-
maze (where the rat had two choices and a dry platform was placed at the end of the 
arm of the correct choice as a reward), including increased incorrect arm entries and a 
longer time to reach the platform (104), both of which indicate cognitive deficits. These 
rodent studies confirmed that the magnitude  of the cognitive effects observed 
correlated with the duration of the ID diet, and that the resulting deficit in learning was 
evident before a significant change in blood hemoglobin levels was apparent (104). 
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Possible mechanisms/explanations of ID-caused cognitive deficits 
From the research with rodents, three possible explanations for the acute 
cognitive deficits caused by ID have emerged (70). The first focuses on the fact that 
circadian rhythms and the ability to thermoregulate are affected by ID (105-107). 
Changes in either of these important bodily mechanisms may affect an infant’s 
performance on the Bayley’s Scale of Infant Development directly, or affect a child’s 
ability to learn during the deficiency, causing permanent cognitive deficits (70). 
The second proposes that ID may impact the dopamine pathway to mediate 
certain forms of learning (70, 108). Disruptions of this pathway have been shown to 
reduce performance of rats in a Morris water maze (109) and passive avoidance task 
(110). Since ID has been shown to interfere with the dopamine D2 receptor (111-113), it 
is possible that the disruption of this pathway is the cause of the cognitive deficits 
observed. 
The third possibility focuses on the hippocampus and its vulnerability to stressors 
(i.e., nutritional or otherwise) in the neonatal brain. It has been shown that experiencing 
ID as a neonate can result in a greater loss of neurons after a hypoxic event (114) and 
also that the hippocampus is more susceptible to stresses than other brain regions 
(115). This hippocampal vulnerability may result in a bigger change in neurotrophic 
factors (23) and myelination (26) in the hippocampus compared to other brain regions 
and play a role in the decrease in cognitive ability that ID neonates experience 
compared to controls. 
Long-term cognitive impairment in response to ID in the neonate is thought to be 
caused by several reasons. ID decreases the myelination that occurs in the brain during 
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that time, which can affect the speed at which signals move through the brain (32). Also, 
differences in neurotrophic factor expression that affects neuron growth and 
development may be responsible for these long-term cognitive deficits (24). 
 
2.4 NEONATAL BRAIN DEVELOPMENT 
 Early-life nutrition can have important consequences for the neonate, such as 
leaving it more vulnerable to stressors (8, 9, 116). The potential effects of postnatal ID 
on brain growth and cognitive development are of particular interest, as the human brain 
undergoes extraordinary growth during the first years of life (10, 11). Disruption of these 
early developmental processes may have long-lasting, and even permanent, effects on 
brain structure and function (12, 13). The hippocampus is a particularly important brain 
region involved in learning and memory, which is highly vulnerable to various stressors 
during this sensitive period (14).  
Peripheral infection during this time period has been shown to decrease cognitive 
performance in rats, and this deficit can last into adulthood (117, 118). These cognitive 
difficulties may be due to an inflammatory immune response in the brain resulting from 
the infection, which can elevate levels of proinflammatory cytokines in the hippocampus 
such as IL-1 (119), IL-6 (120), and IL-10 (121). Microglia are the resident macrophages 
of the brain and respond to infection by becoming active and producing these 
inflammatory cytokines (122). A marker of immune activation in the these microglia cells 
is the major histone compatability complex II (MHC II) expression on the surface of the 
cell , which increases in response to infection (121). It is possible that nutritional insults 
have a similar effect on the brain. 
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 Many neurotrophic factors are important in neonatal brain development, including 
brain derived neurotrophic factor (BDNF), nerve growth factor (NGF), myelin basic 
protein (MBP), and others. For example, BDNF is involved in neuron growth and 
development, including neuron migration and survival, growth and branching of 
dendrites and axons, and neurotransmitter synthesis and release (123). These functions 
are particularly important in the developing brain and have been shown to influence 
learning and memory, as well as plasticity (123-125). ID has been shown to reduce 
BDNF expression in the rat brain, especially the hippocampus (23, 24). NGF is another 
neurotrophic factor that is important during development. NGF promotes the survival 
and plasticity of neurons and regulates the production of neurotransmitters (125, 126). 
NGF mRNA expression in the hippocampus has been shown to increase during ID (23). 
Synaptophysin (SYN) is a protein associated with the development and maintenance of 
synapses, which are important in the plasticity of neurons (127) as well as the 
production of synaptic vesicles (which are important in cell signaling) (128). Decreased 
levels of SYN have been associated with cognitive declines in Alzheimer’s Disease 
(129), however synaptophysin has not been studied in relation to ID. In addition, N-
methyl-D-aspartate receptors ( NMDAR) are also important in mediating the formation 
of synapses and synapse activity in the developing brain (130). Myelin basic protein 
(MBP) is a protein involved in myelination of neurons, and its presence correlates with 
the amount of myelination occurring on the neurons (131).  Myelination has been 
correlated with cognitive ability (132) and others have shown that myelination and the 
concentration of MBP is decreased by ID (25, 26). 
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2.5 THE PIG AS A MODEL FOR HUMANS 
The neonatal piglet is an emerging animal model for studying neurodevelopment 
in humans. Piglet anatomy shows strong parallels with human brain structure (27) and 
perinatal growth patterns (28), as well as similar cardiovascular physiology, 
dermatology, digestive physiology, immunology, and metabolism (133). These 
similarities make the piglet an excellent model for assessing the neurological effects of 
nutritional stressors during the neonatal period. Piglets are also a suitable model for ID, 
as they are born with limited stores of iron (approximately 50 mg), just as humans have 
limited stores, and can quickly become deficient  without a supplement or adequate 
dietary source (29). Finally, neonatal piglets are easy to test in a behavioral paradigm, 
as they are mobile at birth and can be raised on milk replacer starting at  two days of 
age (133). Several cognitive behavioral tasks have been developed for piglets to test for 
alterations in learning and memory (134-136). 
 
2.6 IRON AND THE IMMUNE SYSTEM 
 The relationship between ID and the immune system is complex and is difficult to 
separate from general malnutrition. It is also important to note that most bacteria require 
iron for growth and reproduction, requiring the body to sequester it, so supplementation 
with iron can actually increase the incidence of infection in many cases (137). It has 
been observed that children suffering from IDA are sick more often than non-iron 
deficient children (70). ID can cause inflammation, while in turn, inflammation has been 
shown to cause anorexia, which is also a symptom of ID (70). 
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 It has been shown that ID delays the development of cell-mediated immunity 
(138), most likely due to the effects of ID on cell growth and division, but does not affect 
humoral immunity (72). ID also reduces immune system function by decreasing the 
amount of nitrous oxide and peroxide that can be produced (because iron is a cofactor 
in those enzymes) (72). This decreases the ability of the immune system to destroy 
invasive bacteria and leaves the organism more vulnerable to infection. 
Production of several cytokines, or signaling molecules involved in proper 
immune functioning, have also been shown to be affected by ID.  Levels of IL-1and IL-6 
(pro-inflammatory cytokines) were increased in rats kept on an ID diet, while IL-10 and 
IL-2 (anti-inflammatory cytokines) levels decreased (70). This increase in pro-
inflammatory signaling and decrease in anti-inflammatory signaling may be the reason 
behind the chronic inflammation experienced by children with IDA (70). 
 
2.7 SUMMARY 
 Neonatal ID is a serious public health concern throughout the world. Because 
iron is necessary for many different functions in the body, a deficiency during critical 
periods of growth can have long-term consequences. One of these consequences is 
cognitive impairments, which have been shown in several models at various time points 
during development. The pig model is an excellent model for studying iron deficiency 
and its effects on the brain because of its similarity to humans. 
 Future directions for research on iron deficiency could include further 
development of the pig model. mRNA levels in the pig at various time points could also 
be studied to possibly see an effect in the expression of neurotrophic factors or other 
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proteins important for brain development. The use of the SWI method to determine iron 
concentration in deficiency conditions should also be further explored. Finally, adding a 
second hit of an infection to this model might reveal differences in immune activation 
and cytokine production.  
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CHAPTER 3 
METHODS 
3.1 Animals and housing  Twelve female and twelve intact male Yorkshire piglets from 
six separate litters from the University of Illinois swine herd were naturally farrowed 
(with only the adequate group receiving an iron dextran shot, which is standard industry 
practice) and brought to the animal facility at 48 h of age (after adequate colostrum 
consumption). Sow milk is very deficient in iron (approximately 1 ppm) so consumption 
of colostrum would have a minimal effect on the experiment (133). Piglets were housed 
individually in clear acrylic-sided cages (0.75 m L x 0.58 m W x 0.47 m H) as previously 
described (134, 139), with additional items provided for enrichment. Room temperature 
was kept at 27 ºC and radiant heaters above the piglets also provided supplemental 
heat. A twelve hour light/dark cycle was maintained with light from 07:00 h to 19:00 h. 
Animals were weighed each morning. After completion of the study (postnatal d 29) 
piglets were anesthetized using a telazol:ketamine:xylazine solution (50 mg of tiletamine 
plus 50 mg of zolazepam reconstituted with 2.5 mL ketamine [100 mg/mL] and 2.5 mL 
xylazine [100 mg/mL]; Fort Dodge Animal Health, Fort Dodge, IA); the anesthetic 
combination was administered i.m. at 0.15 mL/4.5 kg BW. After verifying anesthetic 
induction, piglets were sacrificed via i.c. administration of sodium pentobarbital 
(86 mg/kg of BW; Fatal Plus®, Vortech Pharmaceuticals, Dearborn, MI). All procedures 
were approved by the University of Illinois at Urbana-Champaign Institutional Animal 
Care and Use Committee. 
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3.2 Diets  Powdered milk replacer diets were formulated and mixed at the University of 
Illinois. Upon arrival at the animal care facility, 2 male and 2 female piglets were placed 
on one of three diets (Table 3-1): a control diet (100 mg Fe/kg of solids), a mildly 
deficient diet (25 mg Fe/kg of solids), or a severely deficient diet (10 mg Fe/kg of solids). 
Two replicates of the experiment were conducted, for a total of 4 males and 4 females 
per treatment. Milk was freshly reconstituted four times daily at a final concentration of 
206 g (milk solids)/L using deionized water. Milk was supplied at up to 75 mg/kg of BW 
(based on daily recorded weight) each meal, for a total of up to 300 mg/kg of BW/d, 
approximately 85% ad libitum feeding.  Meals were provided in bowls located in the 
home cage at the conclusion of cognitive testing and every four hours thereafter. No 
extra water was provided. No milk was provided for an 8-h period prior to the start of 
behavioral testing to ensure that the piglets remained motivated for the milk rewards 
used in the task. 
 
3.3 Hematocrit and hemoglobin analysis  Blood was collected from the jugular vein 
on postnatal d 7, 14, 21, and 28. Hematocrit was obtained by spinning blood collected in 
capillary tubes in an Autocrit II Centrifuge (BD-Clay Adams, Franklin Lakes, NJ) for 3 
min at 13,700 g. Hemoglobin concentration was measured by a colorimetric 
cyanmethehemoglobin method following the manufacturer’s protocol (Product code: D 
5941; Sigma-Aldrich Co., St. Louis, MO). Absorbance was determined by a plate reader 
(Bio Tek, Winooski, VT). 
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3.4 Color analysis  Color is a very simple and easily measured feature that is 
commonly used to determine meat quality, especially redness, which is often associated 
with freshness by the consumer (140). In the L*a*b* color space system, a* refers to a 
position along the green/magenta color gradient, so only the a* values were compared 
to determine redness in this experiment. On postnatal d 28, the pallor of the nose of 
each piglet was measured by a colorimeter (Konica Minolta, Ramsey, NJ) and a* values 
of the L*a*b* color space data were compared. 
 
3.5 Activity score To assess the magnitude of the symptoms of anemia caused by iron 
deficiency (poor growth and fatigue), body weight and actiivity level were measured 
beginning on postnatal d 4. For activity level, piglets were removed from their home 
cages to an adjacent room, where activity level was recorded with a video camera 
mounted to the ceiling for 5 min each day. The piglets were placed in an enclosure (175 
cm x 114 cm), constructed of white plastic wall panels with black rubber flooring, and 
provided  with a hand towel and a different toy randomly selected from five objects. 
Total distance moved in the enclosure during the 5-min period was tracked using 
commercially available software (EthoVision 3.1; Noldus Information Technology Inc., 
Leesburg, VA). Total time spent interacting with the objects was determined from the 
video records by a single observer using a stopwatch. Total distance moved (cm) and 
time spent interacting with objects were graphed against each other for the iron 
adequate group. An equation for the linear fit of the graph (y = -4.694x + 4965) was 
used to relate the two measures. Every second of activity was valued at 4.694 cm and 
this was added to the total distance traveled to get a composite activity score number 
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for each piglet on each day. These scores were then normalized by dividing each one 
by the maximum to create the final “activity score”. 
 
3.6 Cognitive testing  Piglet spatial learning and memory was assessed using a clear 
plastic plus maze (double T-maze) with extra-maze visual cues (Figure 3-1), described 
previously (135). The maze consisted of two start arms (north and south) and two 
reward arms (east and west). Start arm location was randomly alternated throughout 
testing to ensure that the piglets used the provided visual cues, not a body-centric 
mechanism, for solving the task (141). Starting at 19 days of age, piglets were tested 
each morning, from approximately 07:00 h and 11:00 h, following overnight food 
deprivation. Testing consisted of 10 trials per day for 9 days. The first 6 days consisted 
of the acquisition phase, where the piglets learned to locate the food reward (i.e., 3 mL 
of the severely deficient diet per trial) in a constant place and direction (e.g., east). The 
last 3 days were the reversal phase, where the correct reward arm was switched (e.g., 
west), forcing the piglet to re-learn the new location. A learning criterion of 80% correct 
was established for the acquisition phase. Piglets that refused to participate in the task 
(make a decision within the minute allowed) for all ten trials for two days in a row were 
dropped from testing. Piglets were tracked live using the same software employed for 
measurement of activity level (EthoVision 3.1). The first repetition of piglets was not 
familiarized to handling procedures prior to cognitive testing, unlike the second group, 
which resulted in the need for two additional days at the start of acquisition training for 
piglets to become habituated to the maze. As no statistical differences in the 
performance of piglets were found between d 3 of repetition 1 and d 1 of repetition 2 
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(data not shown), data from both groups were combined beginning on these days for 
analysis.  
 
3.7 Brain iron analysis by mass-spectroscopy Approximately 0.5 g of tissue from 
both the hippocampus and prefrontal cortex from each piglet were taken following 
euthanasia on postnatal d 29, rinsed in phosphate buffered saline, and stored at -80°C 
until processing. Samples were brought to the University of Illinois Microanalysis 
Laboratory and digested in a Multiwave 3000 Microwave digester (Perkin Elmer / Anton 
Parr, Waltham, MA) with a high pressure rotor (60 bar), and the addition of a purified 
acid cocktail following the manufacturers specifications. The digested samples were 
analyzed for iron concentration by the SCIEX ELAN DRCe Inductively Coupled Plasma 
Mass-Spectrometer (Perkin Elmer / Anton Parr, Waltham, MA). 
 
3.8 Brain volume and iron content as measured by magnetic resonance imagery 
(MRI) On postnatal d 29, piglets (n = 4 per treatment) were transported to an imaging 
center on campus and anesthetized using a telazol:ketamine:xylazine solution 
(described above), which was administered i.m. at 0.15 mL/4.5 kg BW. Piglets, along 
with vials of standard iron solutions placed next to the piglets head, were scanned using 
a Siemens MAGNETOM Trio 3T Imager using a Siemens 32-channel head coil 
(Siemens, Erlangen, Germany). Brain images were acquired using a 3D T1-weighted 
magnetization-prepared rapid gradient-echo sequence (MPRAGE), as previously 
described (142), with a final voxel size of 0.35 mm x 0.35 mm x 1.0 mm.  Brain iron 
concentration was determined using the 3T Imager’s Susceptibility-Weighted Imaging 
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(SWI) package (developed by Haacke et al. (85, 86)) and the protocol developed by Dr. 
Arthur Kramer, Beckman Institute, University of Illinois. 
Volumes were determined using a protocol previously described (142). In brief, 
images were analyzed using 3D visualization software (AMIRA, Visage Imaging, San 
Diego, CA), with criteria for the for the hippocampus based on a stereotaxic atlas (143). 
Manual segmentation of the whole brain and hippocampus was performed on a Wacom 
Cintiq 21UX graphic input screen with included stylus (Wacom, Vancouver, WA). These 
segmentations were also used to create a three dimensional reconstruction of the brain 
(Figure 3-2). To determine iron values in the hippocampus, the segmentation used for 
volume analysis was applied to the SWI image and the voxel intensities (brightness 
values) were compared against the standard iron solutions that were placed in the MRI 
machine at scanning (protocol summarized in Appendix 1). 
 
3.9 Quantification of microglia activation Microglia cells were isolated according to a 
protocol previously described by others (121). Approximately 0.5 g of hippocampal 
tissue was collected from each piglet and rinsed in phosphate buffered saline (PBS). 
Tissue was pushed through a 70 µm nylon mesh cell strainer (BD Biosciences, San 
Jose, CA) using Dulbecco’s phosphate buffered saline (DPBS; Sigma, St. Louis, MO) 
with 0.2% glucose for homogenization and spun at 600 x g for 6 min to form a pellet. 
The supernatant was removed and the pellet was resuspended in a 70% isotonic 
Percoll (GE Healthcare, Waukesha, WI) solution. Layers of 50%, 35% and 0% isotonic 
Percoll were overlayed to form a discontinuous gradient, which was then spun for 20 
min at 2000 x g. The microglia layer, located at the interface of the 50% and 70% 
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layers, was removed and spun at 600 x g for 6 min to form a pellet. This pellet was 
resuspended in flow buffer (PBS with 1% bovine serum albumin; Fisher, Waltham, MA), 
0.1% sodium azide (Sigma, St. Louis, MO), and 20mM glucose (Sigma, St. Louis, MO).  
The cells were stained with antibodies for receptors used to identify microglia cells: 
CD11b (Biolegend, Sand Diego, CA) and CD45 (AbD Serotec, Raleigh, NC), as well as 
MHC II (Antibodies Online, Atlanta, GA) as a marker of cell activation. MHC II 
expression was measured using the LSR II flow cytometer (BD Biosciences, San Jose, 
CA) and quantified using FCS Express (De Novo Software, Los Angeles, CA). 
 
3.10 Real time PCR  Samples of the prefrontal cortex and hippocampus of each piglet 
were collected and stored in RNA later (Ambion, Carlsbad, CA) at -80 ºC until 
processing. Total RNA from approximately 100 mg of hippocampal and cortical tissue 
was isolated using the Tri Reagent protocol (Sigma, St. Louis, MO). A QuantiTect 
Reverse Transcription Kit (Qiagen, Valencia, CA) was used for cDNA synthesis with 
integrated removal of genomic DNA contamination according to the manufacturer’s 
protocol. Quantitative real-time PCR was performed using the Applied Biosystems 
(Foster, CA) Assay-on Demand Gene Expression protocol, as previously described 
(144). In brief, cDNA was amplified by PCR where a target cDNA was amplified 
simultaneously using an oligonucleotide probe with a 5′ fluorescent reporter dye (6-
FAM) and a 3′ quencher dye (NFQ) (Applied Biosystems [Foster, CA], genes 
summarized in Table 3-2). Conditions for the PCR procedure included: 50°C for 2 min, 
95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. 
Fluorescence was determined on an ABI PRISM 7900HT-sequence detection system 
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(Perkin–Elmer, Forest City, CA). Data were analyzed using the comparative threshold 
cycle (Ct) method (145) and results are expressed as fold change relative to the 
endogenous control (RPL19). 
 
3.11 Statistical methods Data analysis was conducted using the MIXED procedure of 
the Statistical Analysis Systems software (SAS Institute Inc., Cary, NC). Hematocrit and 
hemoglobin, activity score, and cognitive task data were analyzed as a two-way (diet × 
day) repeated measures ANOVA. All other data were analyzed as a one-way ANOVA to 
determine the effects of treatment. Post-hoc paired contrasts were used to further 
examine interactive effects between all treatments at each time point. Correlations and 
curve fits were done using Proc Corr and Proc Reg. Statistical significance was 
accepted at P < 0.05, statistical trends at P < 0.10. Data are presented as Least 
Squares Means (LSM) ± Standard Errors of the Means (SEM).  
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CHAPTER 4 
RESULTS 
4.1 Hematocrit and hemoglobin analysis Repeated measures ANOVA revealed a 
diet (P < 0.0001) and day (P <  0.0001) effect for hematocrit levels. However, there was 
no significant diet × day interaction found for hematocrit during the four week 
experiment (P = 0.10). Similar to hematocrit, there was a diet (P <  0.0001) and day (P <  
0.0001) effect observed for hemoglobin. In addition, a diet × day interaction was found 
(P = 0.0160). Post-hoc paired contrasts for each day revealed that both hemoglobin 
(Fig. 4-1A) and hematocrit (Fig. 4-1B) levels varied over time, creating three separate 
groups by week three, which was also apparent through week four of the experiment.  
 
4.2 Color analysis The a* values (the magenta/green values of L*a*b* colorspace data) 
showed a significant effect of the dietary treatment (P < 0.0001) on nose color at d 28 
(Fig. 4-2A). The a* values for both the mildly deficient and severely deficient groups 
were significantly different from the adequate group (P < 0.0001, both comparisons) and 
the severely deficient group was different from the mildly deficient group (P = 0.0259). 
These values also correlated linearly with the hematocrit measurements for those 
animals (R2 = 0.76; Fig. 4-2B). 
 
4.3 Activity score and body weight No significant effect of the dietary treatment was 
found between groups for body weight (P = 0.92); however, there was a day effect (P < 
0.0001) and a diet × day effect (P < 0.0001; Fig. 4-3A). No significant diet × day 
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interaction was found for the composite activity score between the diets (P = 0.12; Fig. 
4-3B) or for average interaction time with the objects provided (P = 0.57; Fig. 4-3C). 
 
4.4 Cognitive testing The number of correct choices in the maze during acquisition 
was affected by diet (P = 0.0424) and day (P = 0.0021). However, no significant diet × 
day interaction was found for the acquisition phase of cognitive testing (P = 0.24; Fig. 4-
4A). However, paired contrasts between the first and sixth day of acquisition for each 
diet revealed that both the adequate and mildly deficient groups performed significantly 
better in the task over time (P = 0.0006 and P = 0.0020, respectively), while the 
severely deficient group did not improve (P = 0.39). Two piglets (one in the mildly 
deficient and one in the severely deficient group) were dropped from testing during this 
phase due to refusal to perform the task (no choice was made for all ten trials for two 
consecutive days). For reversal testing, there was a significant diet (P = 0.0329) and 
day (P < 0.0001) effect. A significant diet × day interaction was also found for the 
reversal phase of testing (P = 0.0321). Post-hoc comparisons revealed that both the 
mildly deficient and severely deficient groups were significantly different from the 
adequate group on day two (P = 0.0374 and P = 0.0132, respectively) and three (P = 
0.0352 and P = 0.0003, respectively) of testing.  
 Average latency to reward arm choice during acquisition (Fig. 4-4B) revealed a 
trend for a day effect (P = 0.09) and a diet × day effect (P = 0.09). In addition, there was 
a significant treatment effect (P = 0.0017). Post-hoc tests revealed significant 
differences between the average latency to choice for the adequate group versus the 
mildly deficient group (P < 0.0001) and the severely deficient group (P < 0.0001). There 
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was also a significant difference between the mildly deficient group and the severely 
deficient group (P = 0.0001). The latency to reward arm choice during reversal showed 
similar results, with significance for diet (P = 0.0124), but not day (P = 0.26) or diet × 
day (P = 0.12). Post-hoc tests revealed significant differences between the average 
latency to choice for the adequate group versus the mildly deficient group (P = 0.0034) 
and the severely deficient group (P < 0.0001). There was also a trend towards a 
difference between the mildly deficient and the severely deficient group (P = 0.0871).  
Average distance moved per trial during acquisition (Fig. 4-4C) had a significant 
diet effect (P = 0.0008) and day effect (P = 0.0038), but not a diet × day effect (P = 
0.31). During reversal, average distance moved per trial did not have a significant diet 
effect (P = 0.29) or diet × day effect (P = 0.18). However, day of testing significantly 
impacted this measure (P = 0.0052). 
 
4.5 Brain iron analysis by mass-spectroscopy No significant effect of diet was found 
for the iron content in the prefrontal cortex (P = 0.29; Fig. 4-5A). However, a significant 
effect of diet was found in the hippocampus (P = 0.0039; Fig. 4-5B), with the adequate 
group being significantly different from both the mildly deficient (P = 0.0099) and 
severely deficient (P = 0.0016) groups. However, there was no difference found 
between the mildly deficient and severely deficient groups (P = 0.38).  
 
4.6 Brain volume and iron concentration as measured by MRI No significant effect 
of dietary treatment was found between the groups for whole brain volume (P = 0.52; 
Fig. 4-6A) or hippocampal volume (P = 0.33; Fig. 4-6B). No significant effect of dietary 
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treatment was found between the groups for hippocampal iron concentration (P = 0.71; 
Fig. 4-6C). 
 
4.7 Quantification of microglia activation Microglia were isolated from hippocampal 
tissue at between 75 and 90% purity. No significant effect of dietary treatment was 
found for MHC II expression (a marker for microglia activation) (P = 0.33; Fig 4-7). 
 
4.8 Real time PCR No significant differences in gene expression between groups were 
found for either the hippocampus (Fig. 4-8A)or prefrontal cortex (Fig. 4-8B). Genes 
involved in brain development were tested including: BDNF (P = 0.44 and P = 0.45, 
respectively), NGF (P = 0.17 and P = 0.55), SYN (P = 0.74 and P = 0.91), NMDAR (P = 
0.80 and P = 0.83), and MBP (P = 0.98 and P = 0.87) at postnatal d 29. In addition, no 
significant differences were found in these regions for the following cytokines, IL-1 (P = 
0.78 and P = 0.74, respectively), IL-6 (P = 0.90 and P = 0.50), and IL-10 (P = 0.59 and 
0.91), at the same time point. 
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CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
 The hematocrit and hemoglobin data indicate that piglets fed the mildly and 
severely deficient diets had lower iron levels throughout the study than those fed the 
adequate diet, which was particularly evident during cognitive testing. We were 
successful in creating three statistically distinct groups of piglets with varying iron status 
by week three, which was maintained for the remainder of the experiment. These values 
were similar to those found in previous research (146-148) and fall into the established 
hemoglobin categories for iron adequate piglets, mildly iron deficient piglets, and 
severely iron deficient piglets (29). The fact that there was a diet by day interaction for 
hemoglobin, but not hematocrit values, shows that hemoglobin may be a more sensitive 
measure of iron level (149).  
 Color is a very simple and easily measured feature that has been used to 
determine meat quality, especially the presence of redness pigment. The a* data from 
the color analysis of the piglets’ noses was strongly correlated with the hematocrit 
values, indicating that this measure could be an easy and non-invasive method to 
assess iron status in piglets. The colorimeter also has the potential to be used to 
measure iron status in humans, as it has been previously utilized to determine UV 
radiation exposure in people (150).  
 Some of the major symptoms of anemia in piglets are weakness, lethargy, and 
poor growth (29), which could negatively impact the results of cognitive testing. To verify 
that the results obtained during cognitive testing were due to cognitive deficits only, we 
measured body weight and piglet activity level. Although there was a significant diet by 
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day interaction for body weight in our study. This is likely attributed to the tremendous 
growth rate observed in developing pigs, approximately 1000% over the first 6 wks of 
life (133). The observation of no difference between body weights for the different 
dietary treatments, unlike other studies which found that iron deficiency reduced body 
weight (29, 151), is likely a result of the body weight dependent caloric restriction that 
the piglets were placed on throughout the experiment. The lack of a dietary effect for 
body weight indicates that poor growth was not a factor impacting cognitive testing 
performance. Additionally, there was no significant difference between diets for the 
average composite activity score, or the average time spent interacting with objects, 
demonstrating that the iron deficient piglets were not excessively fatigued and still 
maintained normal behavior.  Due to the lack of a dietary effect for all three measures, it 
can be concluded that the differences between groups observed during cognitive testing 
can be attributed to cognitive deficits in learning and memory and not to excessive 
fatigue caused by iron deficiency.  
 Examining the cognitive testing data, it was apparent that both the adequate and 
mildly deficient groups acquired the task, reaching the 80% learning criterion, by days 
four and six of the acquisition phase (respectively). However, the severely deficient 
group never reached this level of performance, indicating that severe iron deficiency 
prevents the learning of the less-difficult acquisition task. The reversal phase is 
considered a more complex task, as it is more difficult to forget and relearn a strategy, 
than to simply learn a strategy during acquisition (134, 152). This more sensitive 
measure allowed for the separation of the mildly deficient group from the adequate 
group, as piglets with mild iron deficiency had a significantly lower percent correct 
36 
 
during reversal testing than controls. These data demonstrate the dose-dependent 
manner in which iron deficiency affects cognitive performance in a hippocampal-
dependent T-maze task. 
 Latency to make a reward arm choice in both acquisition and reversal testing 
were significantly higher in both the mild and severely deficient groups compared to the 
adequate group. There were also significantly longer latencies during acquisition in the 
severely deficient group than the mildly deficient group, but not during reversal testing. 
These data suggest that iron deficiency results in slower decision-making, indicating 
cognitive impairment, which is similar to that seen in water maze data with rats (104). 
Latency to reward arm choice during both the acquisition and reversal phases of testing 
mirror the performance data, again demonstrating a dose-dependent effect of iron on 
cognitive performance.  
 The average distance moved per trial was significantly different between groups 
for acquisition, with the severely deficient piglets moving the most and the control 
piglets moving the least distance during trials. These data not only indicate that iron 
deficiency did not result in fatigue that could have hampered performance (also 
supported by the lack of difference observed in distance moved per trial in the reversal 
phase), but that iron deficient piglets were less definitive with their choices, taking a 
longer path length to make a reward choice, than controls (104). This, along with the 
observance of piglets in all groups consuming the rewards (indicating there was no lack 
of motivation), shows that cognitive deficits in learning and memory were the reason for 
lower performance of the iron deficient piglets in the T-maze task. 
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 To explain the differences in cognitive performance between groups, brain iron 
content in the hippocampus and prefrontal cortex were analyzed. Differences in iron 
concentration were found in the hippocampus for the iron deficient groups compared to 
controls, indicating that a decreased iron content in this area was most likely 
responsible for the cognitive deficits found in the cognitive task. This is similar to 
findings that showed that the hippocampus is essential for the development of many 
behaviors (including learning and memory), and that low iron in this area negatively 
impacts the development of these behaviors (153). No differences were found between 
groups for iron in the prefrontal cortex, which coincides with previous experiments which 
found that the hippocampus is one of the more vulnerable regions of the brain (14, 82). 
 No treatment differences were found in whole brain or hippocampal volume in 
piglets at week four, unlike the decreased volumes observed in iron deficient rats (12) 
and humans (16). This may be due to the fact that body weights of iron deficient piglets 
were not found to be different from controls, and decreased body weight, such as that 
caused by a low protein diet, has been found to  decrease brain weight and size in the 
rat (154). It is also possible that since piglets develop very rapidly during this time (133), 
that this large amount of growth overshadowed any treatment effects on brain volumes. 
 No significant differences were found for hippocampal iron concentration using 
the SWI method. This method is currently applied in clinical practice to help detect 
regions with higher iron concentrations and micro bleeds in the brain (85). However, this 
is the first attempt to use this technique to detect deficiency conditions. One potential 
issue is that low iron in a brain region results in higher concentrations of water, which 
can reduce the accuracy of the measurements (86). The hippocampal iron values 
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obtained by the SWI method were much lower than those reported by mass- 
spectrometry, so it is possible that the SWI method is not a useful tool to determine 
deficiency conditions. However, the SWI scans were not captured at the same 
resolution as the MPRAGE scans used to segment the brain regions and needed to be 
resampled for analysis; therefore, the lower iron levels may be due to poor image 
quality, not sensitivity of the method. Additionally, the SWI images for six of the twelve 
subjects were removed from the data set, as they were of unusable quality.  Due to 
these complications, this data does not validate nor disprove the use of the SWI method 
for determining iron deficiency in the brain.  
 Dietary treatment did not alter the percent of hippocampal microglia cells 
expressing MHC-II, a marker for cell activation. This indicates that the immune system 
was not activated by iron deficiency, which is different from that observed in children 
with IDA, who show signs of chronic inflammation (70). Increased inflammation due to 
iron deficiency may only result in microglia activation after another stress, or ‘second hit’ 
such as infection, has been applied (155). 
 No differences were found in gene expression between groups for neurotrophic 
factors (BDNF and NGF), synaptophysin, NMDAR, MBP, and various cytokines (IL-1, 
IL-6, and IL-10) at postnatal day 29 in either the prefrontal cortex or hippocampus. 
These results were surprising, as other studies using rats have found an increase in 
NGF in the iron deficient hippocampus (23) and a long term reduction in BDNF, even 
after iron was restored in the diet (24). No treatment differences in the expression of 
these genes may highlight differences between rodent model and pig models, which will 
need to be investigated further to truly understand the value of using piglets as a model 
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for humans. The lack of differences in mRNA expression of MBP in this study, even 
though others have shown that myelination is affected by iron deficiency (25, 26), may 
be due to the deficiency only affecting this process post-transcriptionally or at different 
time points than the one studied. mRNA expression of several cytokines was also 
unchanged due to iron deficiency; however, it is possible that with a “second hit” (i.e., an 
infection) that differences in mRNA expression would be seen.  
 Reduced dietary iron created both a mild and severe deficiency in piglets, which 
affected blood hematocrit and hemoglobin, as well as the iron status of the 
hippocampus. This experiment clearly demonstrated a dose-dependent reduction in 
hippocampal-dependent spatial learning in iron deficient piglets, which is likely due to 
low iron in the hippocampus. This piglet model will be a very useful tool in future studies 
for determining the effects of iron deficiency, or other nutrient deficiencies or 
supplementations, on brain growth and development. 
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CHAPTER 6 
FUTURE DIRECTIONS 
 There are many possible directions to take to expand on this study of iron 
deficiency and its effects on learning and memory. Since no differences were found for 
mRNA levels of several proteins involved in brain growth and development as well as 
several cytokines, different time points could be tested to see if there is a difference in 
the expression of these genes earlier or later in life. Others have found differences in 
the expression of BDNF and NGF in the rat hippocampus (23, 24), so it is possible that 
these differences could exist in the pig as well, only at a time point other than four 
weeks of age. It is also possible that there is more regulation of these genes farther 
downstream in the pathway (posttranscriptional or posttranslational) and measuring the 
levels of these proteins might reveal a difference caused by iron deficiency 
 The dopamine pathway is another possibility for exploration, as it was not looked 
into during this study. It is known that iron deficiency affects the dopamine pathway by 
interfering with the dopamine D2 receptor (111-113), which may be the cause of the 
observed cognitive deficits. Measuring mRNA and protein levels of the dopamine D2 
receptor, as well as other proteins related to the dopamine pathway, may help 
determine if the dopamine pathway plays a role in the cognitive deficits caused by iron 
deficiency.  
 In terms of assessing the effect of dietary iron deficiency on brain iron content, 
the SWI method could be optimized (85). Repeating this method using the same size 
and resolution for the MPRAGE and SWI scans as well increasing the sample size 
would help to resolve this question.  
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 Adding an infectious challenge may also help to resolve the relationship between 
iron deficiency and the immune system in this model. Our data suggest that mildly iron 
deficient piglets had a numerically higher MHC II expression on their hippocampal 
microglia as well as altered expression of inflammatory cytokines compared to controls, 
but it did not reach the level of statistical significance.  Adding a challenge could help to 
discriminate between the groups due to immune stimulus as others have shown that 
iron deficiency weakens the immune system (70), which may reduce the immune 
response in measurable ways. 
 Finally, looking at the effects of neonatal iron deficiency in the piglet without 
caloric restriction may also be an interesting direction to pursue. Since iron deficiency 
has been shown to cause a reduction in appetite and weight in piglets (29), repeating 
this experiment with the piglets that are not food restricted by 15% may reveal 
differences in brain volume that were not seen in this experiment, but were observed in 
rodent studies in response to iron deficiency (12). The neonatal piglet model is ideal for 
studying these ideas, as well as other nutrition experiments involving cognition.   
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FIGURES 
 
 
 
 
Measure of Iron 
Status 
Method of Analysis Change in ID* 
Serum iron Plasma emission spectrometry Decreases 
Total iron-binding 
capacity 
Magnesium carbonate absorption Increases 
Serum ferritin Enzyme-linked immunoabsorbent assay 
(ELISA) 
Radioimmunoassay (RIA) 
Immunoradiometric assay (IRMA) 
Decreases 
Serum transferrin 
receptor levels 
Enzyme-linked immunoabsorbent assay 
(ELISA) 
Increases 
Hematocrit Centrifuging blood Decreases 
Hemoglobin Cyanomethylhemoglobin reaction Decreases 
*Iron Deficiency 
TABLE 2-1 Summary of tests to assess iron status.  
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Ingredient  
 
Basal Diet 
(g/kg) 
Whey 403.00 
Whey protein concentrate 168.68 
Dried skim milk 141.16 
Dry fat 7/60 245.01 
Silica flow agent 20.17 
Calcium phosphate 10.08 
Vitamin/Mineral premix 1.81 
Cornstarch Variable* 
FeSO4 ∙7H2O Variable* 
 
TABLE 3-1 Composition of the dry diet. Cornstarch consisted of 18.28 g/kg of the 
severely deficient diet and was exchanged for FeSO4 •7H2O in the mildly deficient diet 
(16.98 g/kg cornstarch, 1.30 g/kg FeSO4 •7H2O) and the iron adequate diet (10.08 g/kg 
cornstarch, 8.20 g/kg FeSO4 •7H2O). 
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Gene Product number 
IL-1β Ss03393804_m1 
IL-6 Ss03384604_u1 
IL-10 Ss03382372_u1 
N-methyl-D-aspartate receptor 
[NMDAR] 
Ss03373050_u1 
Brain-derived neurotrophic 
factor [BDNF] 
Ss03822335_s1 
Myelin basic protein [MBP] Ss03382372 
Nerve growth factor [NGF] forward: CTCAGGATCCGGACTTGGAGGCCAG 
reverse: GGATGACGACCGCTTGCTCCTG 
Synaptophysin [SYN] forward: GGCCAAGGACGGCTCAT 
reverse: TTTTCCGCCCTTAGCATGTAG 
Reference cDNA (RPL19) Ss03375624_g1 
 
TABLE 3-2 Genes examined by RT-PCR. 
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FIGURE 3-1 Plus maze dimensions (A) and photograph (B). 
  
A 
 
 
0.3 m
0.91 m
Reward bowl
Removable Barrier
Visual cue
0.6 m
B 
 
46 
 
 
 
 
 
 
 
 
FIGURE 3-2 Manual segmentation was performed on images of the piglet brain taken 
by MRI (A), allowing for a reconstruction of the piglet brain (B).  
A
B
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FIGURE 4-1 Weekly measurements of hematocrit (A) and hemoglobin (B) demonstrate 
decreasing values in piglets kept on either a mildly iron deficient diet or a severely iron 
deficient diet, while piglets on the iron adequate diet had stable values. No diet × day 
interaction was observed; however, post-hoc comparisons between all diets for each 
day of testing were determined. Separation of the three dietary treatments occurred by 
week three of the experiment. Data are presented as LSM ± SEM, n = 2-8 per diet. 
Within each graph, means without a common letter differ, P < 0.05. 
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FIGURE 4-2 Differences in nose color (a* values) of piglets kept on a mildly iron 
deficient diet or a severely iron deficient diet at postnatal day 28 (A) show lower a* 
values than piglets kept on an iron adequate diet. The a* values correlated strongly (R2 
= 0.76) with piglet blood hematocrit levels (B). Data are presented as LSM ± SEM, n = 8 
per diet. Within each graph, means without a common letter differ, P < 0.05. Pictures of 
an iron adequate piglet nose (C) and a severely deficient piglet nose (D) are shown. 
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FIGURE 4-3 Body weight (A) over the course of the four week study revealed a 
significant day effect and  diet × day effect. No significant effect was found between 
dietary treatments. Composite activity level (B) and object interaction time (C) over the 
four week study did not reveal a significant diet × day interaction. Data are presented as 
LSM ± SEM, n = 8 per diet. Examples of the tracking of an iron adequate pig (D) and 
severely deficient pig (E) are shown. 
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FIGURE 4-4  Performance in a cognitive spatial T-maze task by iron deficient piglets (A) 
showed that those on the severely deficient diet did not learn the task during the 
acquisition phase of testing, while piglets on the mildly deficient diet performed 
significantly worse than those on the adequate diet during reversal testing. No diet × 
day interaction was found for acquisition, but was observed for reversal testing. Post-
hoc comparisons between all diets for each day of testing were determined. * indicates 
differences from adequate diet, # indicates differences from the mildly deficient diet, 
both at P < 0.05. Additionally, piglets kept on a mildly deficient or a severely deficient 
diet showed significantly longer latencies to make a reward arm choice (B) and moved a 
greater distance in the maze (C) than piglets kept on an iron adequate diet. Data are 
presented as LSM ± SEM, n = 7 for the mildly deficient and severely deficient groups, n 
= 8 for the adequate group. Within each graph, means without a common letter differ, P 
< 0.05. Pictures of an iron adequate pig (D) and a severely deficeint pig (E) trial are 
shown.  
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FIGURE 4-5 Brain iron concentration in the prefrontal cortex (A) and the hippocampus 
(B) of piglets kept on an iron adequate diet, a mildly deficient diet,  or a severely 
deficient diet. No differences were found between diets in the prefrontal cortex, but 
piglets on the mildly deficient or severely deficient diets had significantly lower iron 
content in the hippocampus than those on the adequate diet. Data are presented as 
LSM ± SEM, n = 7-8 per diet. Within each graph, means without a common letter differ, 
P < 0.05. 
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FIGURE 4-6 Brain volume measured by MRI did not reveal a significant effect of dietary 
treatment for the whole brain (A) or hippocampus (B). There was a correlation between 
hippocampal volume and hippocampal iron concentration measured by mass 
spectroscopy (R2 = 0.38) (C). Hippocampal iron concentration determined using SWI 
did not reveal an effect of dietary treament (D). Data are presented as LSM ± SEM, A, 
B, and C, n = 4 per diet; D, n = 2 per diet.  
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FIGURE 4-7 No significant effect of dietary treatment was found for the percent of 
hippocampal microglia cells expressing MHC-II. Data are presented as LSM ± SEM, n = 
8 per diet. 
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FIGURE 4-8 No significant effect of dietary treatment were found in the mRNA 
expression of BDNF, NGF, SYN, NMDAR, MBP, IL-1, IL-6, and IL-10, in the 
hippocampus (A) or prefrontal cortex (B). Data are presented as LSM ± SEM, n = 8 per 
diet.  
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APPENDIX 
PROTOCOL FOR THE MEASUREMENT OF BRAIN IRON CONTENT BY 
SUSCEPTIBILITY WEIGHTED IMAGING 
 
 On postnatal day 29, piglets were transported to the Beckman Imaging Center in 
clear plastic containers. Piglets were anesthetized using a telazol:ketamine:xylazine 
solution (50 mg of tiletamine plus 50 mg of zolazepam reconstituted with 2.5 mL 
ketamine [100 mg/mL] and 2.5 mL xylazine [100 mg/mL]; administered i.m. at 
0.15 mL/4.5 kg BW. Once anesthetized, piglets were placed in the Siemens 
MAGNETOM Trio 3T Imager and scanned using a Siemens 32-channel head coil 
(Siemens, Erlangen, Germany). Brain images were acquired using a 3D T1-weighted 
magnetization-prepared rapid gradient-echo sequence (MPRAGE), as previously 
described (142), with a final voxel size of 0.35 mm x 0.35 mm x 1.0 mm.   
 Brain iron concentration was measured using the 3T Imager’s Susceptibility-
Weighted Imaging (SWI) package and the protocol developed by Dr. Arthur Kramer, 
Beckman Institute, University of Illinois. In order to determine the exact iron 
concentration, a set of glass vials of standard iron solutions was placed in the MRI 
machine next to the piglet’s head. These vials were made by mixing 0.0712 g of FeSO4 
and 50 g of 1 M HCl (92.26 ppm) and performing a serial dilution. The final vials placed 
in the MRI machine contained 11.53, 5.77, 2.88, 1.44, 0.72. 0.36, 0.18, 0.09 and 0 ppm 
of iron.  These vials were placed in a silicone ice cube tray filled with 0.5% agarose gel 
to remove the interface between the glass and air in order to minimize interference 
artifacts. 
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 Once the images were acquired, the MPRAGE images were used to trace the 
vials of iron solution as well as the hippocampus and whole brain using 3D visualization 
software (AMIRA, Visage Imaging, San Diego, CA) with a Wacom Cintiq 21UX graphic 
input screen with included stylus (Wacom, Vancouver, WA). Once the vials and brain 
regions were traced, the MPRAGE tracings were overlaid on the SWI image and the 
average brightness values were calculated using the AMIRA software. The standard 
curve for each pig was developed using this information from the vials and the average 
brightness values from the circled brain regions were quantified using the standard 
curve. 
